Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemiaDeepa Bhojwani, Susan R. Rheingold, Nirali N. Shah et al.|Leukemia|2018Cited by 209
CAR T-cell therapy is effective for CD19-dim B-lymphoblastic leukemia but is impacted by prior blinatumomab therapyVinodh Pillai, Susan R. Rheingold|Blood Advances|2019Cited by 201